T2 Biosystems Reports Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
- Oil falls almost 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
T2 Biosystems (TTOO) Reports Q3 Loss of $0.51
November 1, 2016 5:05 PM EDTT2 Biosystems (NASDAQ: TTOO) reported Q3 EPS of ($0.51), versus ($0.57) reported last year. Revenue for the quarter came in at $1.1 million, versus $1.05 million reported last year.
2016 continues to be a transformative year for T2 Biosystems, said President and Chief Executive Officer John McDonough. We have taken a number of strategic actions to position us for long-term sustainable growth, including our announced partnerships with Allergan and... More
